Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lung Cancer
Proprietary gene Factor 5A1 induces atopsis in lung cancer tumors of mice
May 3rd, 2004
Senesco Technologies, Inc., (SNT) announced that preclinical studies have shown that its proprietary gene, Eukaryotic Initiation Factor 5A1, induces atopsis in lung cancer tumors of mice, while healthy tissue remains unaffected. The company conducted these studies using mice with the same genetic defect that causes lung cancer in humans. The mice spontaneously develop lung tumors due to this defect. Factor 5A1 was injected into the blood stream of the mice and the lung tissue was subsequently analyzed for apoptosis. The data show that the lung tumor cells were specifically targeted to undergo cell death while the surrounding healthy tissue was...
Source: Biotech Business Week (2004-05-03)
|
